Boston Taiwanese Biotechnology Association


BTBA logo

Boston Taiwanese Biotechnology Association (BTBA) is a non-profit organization started in 2012 by a group of Taiwanese graduate students, postdocs and young professionals in the greater Boston area. Our goals are to foster individual career development, to enhance scientific collaborations, to facilitate interactions and to strengthen networking among academic and industrial bioscience communities in Taiwan and US.


Event

Career Development Series

Moderator Workshop

2024-06-09, 1–4 PM ET
BTBA

Register here

Career Development Series

Startups at National Biotechnology Research Park

2024-06-07, 9–10:30 PM ET
Virtual
BTBA

Register here


Meet People, Catch Up With Friends, And Learn


Career Development Series

Drug Delivery—the current development and future

2024-05-19, 1–2:30 PM ET
BioLabs Lecture Hall 1080, (Bri Biological Labs, 16 Divinity Ave, Cambridge, MA 02138)
BTBA

Register here


Podcast


S5 EP.4:藥廠計算生物學家 ft. 周文奇博士、林書弘博士 🎧

Nov 15, 2024

生物學家的工作樣態相當多元,除了在實驗室親手操作之外,也有一類生物學家以不一樣的方式進行科學研究,他們是利用計算方法解決生物問題的「計算生物學家」,或有些人稱為「生物資訊學家」。

...More info


S5 EP.3:腦與神經科學系列:神經膠質細胞基礎研究到臨床試驗的適應與轉換 ft. 蔡蕙歆博士 🎧

Nov 01, 2024

研究領域物換星移,隨著新的研究領域誕生,也有研究領域慢慢淡出人們的視野。而有些曾經冷門的領域,則因為技術進步、新的科學發現,回歸眾人追逐的研究熱點。神經膠質細胞(Neural progenito ...More info


S5 EP.2:美國藥物定價和保險給付體系 ft. Mike Lee 李和昭 MS, MBA 🎧

Oct 15, 2024

美國的高藥價和高醫療支出世界知名,光是處方藥的支出,就佔了全球處方藥物市場的四成,其中十款藥物在 2022 年佔了 Medicare 將近20%的支出(500 億美元),因此最近被《降低通膨法案 ...More info


Blog


腦與神經科學

腦與神經科學系列:藥廠神經藥物開發的現況觀察與前景.黃正球博士 (Dr. Cheng-Chiu (Joe) Huang).訪談摘要

By 文:林書弘.圖:陳政儀.編輯:劉駿 on Nov, 2024

在《生技來一刻》第四季第十二集的訪談中,主持人奕芸邀請到了黃正球博士(Joe),現任Eli Lilly神經科學部門的高階主管,來分享他在神經藥物研發領域的經驗與見解。 黃博士擁有豐富的學術背景與業界經歷,從臺灣大學動物系畢業後一路深造,最終在美國加入生技與製藥產業,專注於神經疾病的藥物開發。這次訪談深入探討了神經科學領域的現況與未來趨勢,對生技業界尤其是從事神經科學的聽眾提供了許多寶貴的洞見。 ...Read more


商業與策略

藥廠投資組合管理.羅盈智醫師 (Dr. Ying-Chih (Paul) Lo).訪談摘要

By 文:林書弘.圖:陳政儀.編輯:劉駿 on Apr, 2024

在現今的生技產業中,投資組合管理與數據分析技術的重要性日益增加。尤其在藥物開發這一高風險領域,有效的策略和先進的技術可以顯著提升研發的成功率及市場競爭力。透過近期與羅盈智醫師(Paul)的對話,我們得以深入了解這些策略如何在實際應用中發揮作用。 Paul目前在美國波士頓的 Novartis 藥廠擔任 Portfolio Data Science 部門的副總監,同時也是波士頓台灣醫師協會的會長。他的職業生涯跨越了醫療、人工智慧和商業策略,這使他對於藥廠如何進行投資組合管理有著獨到的見解。 ...Read more


Sneak peek into the industry

Po-Jen (Will) Yen, Business Development

By Yi-Shan Chen on Mar, 2019

As a scientist in Biotech/Pharma, Business Development to me is a function that usually doesn’t have a lot of interaction with researchers unless they need data from you but the decisions they make influence researchers the most. ...Read more


Sneak peek into the industry

TeYu Chen, Medicinal Chemist

By Yi-ying Chou on Nov, 2018

I always thought that doing biological experiments, like sitting long hours in front of tissue culture hood, can be physically challenging. When I chat with Ryan, I realized that medicinal chemists also have heavy workload on the bench side. In pharmaceutical company, chemists are not allowed to be ...Read more